PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31060409-0 2020 Development of transferrin-bearing vesicles encapsulating aspirin for cancer therapy. Aspirin 58-65 transferrin Homo sapiens 15-26 31060409-4 2020 In this work, we demonstrated that aspirin could be formulated in transferrin-bearing vesicles and that this tumor-targeted formulation could lead to an increase in the anti-proliferative efficacy of the drug in three cancer cell lines in vitro. Aspirin 35-42 transferrin Homo sapiens 66-77 31060409-5 2020 The in vitro therapeutic efficacy of aspirin was significantly improved when formulated in transferrin-bearing vesicles, by about 2-fold compared to that of drug solution. Aspirin 37-44 transferrin Homo sapiens 91-102